CTOs on the Move

NextGate

www.nextgate.com

 
NextGate`s mission is to address the fundamental challenge of data management in the healthcare industry: the uncertainties and missed opportunities caused by duplicate and disconnected records in a data population. While implementing interface engine technology for hospitals in the early 1990s, we noticed a troubling trend – as application systems became integrated and exchanged data with each other, problems caused by duplicate and incomplete patient records (previously confined to one system and its MPI) multiplied and contaminated the data quality of other systems. Because this technical issue could impact a patient`s health, we made it our goal to find a solution. The ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.nextgate.com
  • 3579 E. Foothill Blvd. Suite #587
    Pasadena, CA USA 91107
  • Phone: 626.376.4100

Executives

Name Title Contact Details
Greg Rumple
Chief Information Security Officer Profile

Similar Companies

Allergen Research

Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.

Cecelia Health

Cecelia Health partners with health plans/providers seeking to improve quality measures, and pharmaceutical/medical device companies seeking to improve adherence.

South Shore Hospital

South Shore Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. South Shore Hospital is based in South Weymouth, MA. You can find more information on South Shore Hospital at www.sshosp.org

Xcelience, LLC

Xcelience, LLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Tampa, FL. To find more information about Xcelience, LLC, please visit www.xcelience.com

ARKRAY USA

ARKRAY USA is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.